Abdominal or Transanal TME for Rectal Cancer Therapy
Abdominal or Transanal TME in Therapy of Rectal Cancer: A Retrospective Cohort Study
Sponsor: Cantonal Hospital of St. Gallen
This NA trial investigates Mortality and Postoperative Morbidity and is currently ongoing. Cantonal Hospital of St. Gallen leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Oct 2025 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2025 — Oct 2025 [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Sep 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
▶ Show 2 earlier versions
-
Dec 2022 — Sep 2023 [monthly]
Active Not Recruiting NA
-
Sep 2021 — Dec 2022 [monthly]
Active Not Recruiting NA
First recorded
Jan 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cantonal Hospital of St. Gallen
For direct contact, visit the study record on ClinicalTrials.gov .